Please do not adjust margins
Organic & Biomolecular Chemistry
Page 6 of 10
ARTICLE
Journal Name
according to GP (0 °C, 2 d). Column chromatography (eluent: 177.5 (C=O). HRMS (ESI): m/z calcd. for [C23H35NO6+Na+]:
DOI: 10.1039/C9OB01005J
PE/EtOAc, 30:1, then 15:1) afforded 103 mg (66 %) of target 444.2357, found: 444.2353.
4-(1,3-Dioxolan-2-yl)-3-phenyl-2-(pivaloyloxyimino)butyl pivalate
oxime ester 2i as colorless oil, that solidifies in a fridge. Rf =
2p
0.56 (PE/EtOAc, 9:1, anisaldehyde). mp
= 115-118 °C
1
(PE/EtOAc, 10:1). (E)-2i:(Z)-2i = 1:1. H NMR (300 MHz, COSY,
for (E,Z)-mixture, CDCl3): δ 0.93 (s, 9H, t-Bu), 1.05 (s, 9H, t-Bu),
1.08 (s, 9H, t-Bu), 1.35 (s, 9H, t-Bu), 1.55 (d, J = 6.6 Hz, 3H, (E)-
isomer, Me), 1.73 (d, J = 7.0 Hz, 3H, (Z)-isomer, Me), 5.83 (q, J
= 6.6 Hz, 3H, (E)-isomer, CH–O), 6.13 (q, J = 7.0 Hz, 3H, (Z)-
isomer, CH–O), 7.28-7.43 (m, 5H ((E)-isomer) + 3H ((Z)-isomer),
CHPh), 7.59 (d, J = 7.9 Hz, 2H, (Z)-isomer, CHPh). 13C NMR (75
MHz, DEPT, HSQC, for (E,Z)-mixture, CDCl3): δ 17.8 (Me, (E)-
isomer), 18.2 (Me, (Z)-isomer), 26.7 (Me3C), 26.9 (2 × Me3C),
27.3 (Me3C), 38.4 (2 × Me3C), 38.6 (Me3C), 38.8 (Me3C), 66.3
(CH–O, (Z)-isomer), 70.3 (CH–O, (E)-isomer), 127.4 (CHPh),
128.0 (CHPh),128.1 (CHPh), 128.6 (CHPh), 129.4 (CHPh), 130.1
(CHPh), 131.1 (CPh), 131.2 (CPh), 166.4 (C=N), 167.4 (C=N), 174.3
(C=O), 174.7 (C=O), 177.3 (2 × C=O). HRMS (ESI): m/z calcd. for
[C19H27NO4+Na+]: 356.1832, found: 356.1838.
Oxime ester 2p was obtained from nitro compound anti-1p
(86 mg, 0.35 mmol) and pivaloyl chloride (0.10 mL, 0.10 g,
0.84 mmol) according to GP (r.t., 2 d). Column chromatography
(eluent: PE/EtOAc, 6:1) afforded 131 mg (89 %) of target oxime
ester 2p as colorless oil. Rf
= 0.28 (PE/EtOAc, 5:1,
anisaldehyde). Similar procedure for syn-1p (98 mg, 0.39
mmol) gave 140 mg (86%) of target oxime ester 2p. Similar
procedure for (+)-anti-1p (97 mg, 0.39 mmol) gave 145 mg
(90%, ee = 95%) of target oxime ester (–)-2p. Similar procedure
for (+)-syn-1p (90 mg, 0.36 mmol) gave 133 mg (89%, ee =
96%) of target oxime ester (–)-2p. (–)-(S)-2p: [a]24D = -93.5 (c =
1.0, MeOH, 96% ee, E-isomer). 1H NMR (300 MHz, COSY,
CDCl3): (E)-2p: δ 1.11 (s, 9H, t-Bu), 1.26 (s, 9H, t-Bu), 2.26-2.48
(m, 2H, CH2), 3.77-3.84 and 3.88-3.97 (m, 4H, OCH2CH2O), 4.66
(d, J = 13.1 Hz, 1H, CH2a–OPiv), 4.73 (d, J = 13.1 Hz, 1H, CH2b–
OPiv), 4.76 (t, J = 7.7 Hz, 1H, CHPh), 4.87 (t, J = 4.6 Hz, 1H,
CH(OCH2)2), 7.18-7.35 (m, 5H, Ph). (Z)-2p: δ 1.13 (s, 9H, t-Bu),
3-(tert-Butyldimethylsilyloxy)-2-(pivaloyloxyimino)butyl pivalate
2l
Oxime ester 2l was obtained from nitro compound 1l (111 mg, 1.28 (s, 9H, t-Bu), 2.17 (ddd, J = 13.9, 7.6, 4.3 Hz, 1H, CH2a),
0.48 mmol) and pivaloyl chloride (0.13 mL, 0.13 g, 1.06 mmol) 2.51 (ddd, J = 13.9, 7.6, 5.8 Hz, 1H, CH2a), 3.75-3.85 and 3.87-
according to GP (r.t., 2 d). Column chromatography (eluent: 3.96 (m, 4H, OCH2CH2O), 4.13 (t, J = 7.6 Hz, 1H, CHPh), 4.52 (d,
PE/EtOAc, 20:1) afforded 127 mg (66 %) of target oxime ester J = 14.7 Hz, 1H, CH2a–OPiv), 4.84 (dd, J = 5.8, 4.3 Hz, 1H,
2l as colorless oil. Rf = 0.67 (PE/EtOAc, 5:1, anisaldehyde). CH(OCH2)2), 4.94 (d, J = 14.7 Hz, 1H, CH2b–OPiv), 7.22-7.34 (m,
1
(E)-2l:(Z)-2l = 1:4. H NMR (300 MHz, COSY, CDCl3): (Z)-2l: δ 5H, Ph). 13C NMR (75 MHz, DEPT, HSQC, CDCl3): (E)-2p: δ 27.0
0.07 (s, 3 H, MeSi), 0.09 (s, 3 H, MeSi), 0.90 (s, 9H, t-BuSi), 1.25 (Me3C), 27.1 (Me3C), 34.9 (CH2), 38.6 (Me3C), 38.7 (Me3C), 39.5
(s, 9H, t-Bu-C), 1.29 (s, 9H, t-Bu-C), 1.43 (d, J = 6.5 Hz, 3H, СН3), (CHPh), 62.8 (CH2–OPiv), 64.9 and 65.0 (OCH2CH2O), 102.2
4.67 (d, J = 13.7 Hz, 1H, CH2a–OPiv), 5.12 (d, J = 13.7 Hz, 1Н, (CH(OCH2)2), 127.4 (CHPh), 127.7 (CHPh), 128.8 (CHPh), 137.8
CH2b–OPiv), 5.12 (q, J = 6.5 Hz, 1Н, СН–OTBS). (E)-2l (CPh), 164.2 (C=N), 174.6 (C=O), 177.5 (C=O). (Z)-2p: δ 27.0
(characteristic signals): δ 4.74 (q, J = 6.6 Hz, 1Н, СН–OTBS), (Me3C), 27.2 (Me3C), 37.0 (CH2), 38.7 (Me3C), 38.8 (Me3C), 43.6
4.82-4.92 (m, 2H, CH2–OPiv). 13C NMR (75 MHz, DEPT, HSQC, (CHPh), 58.2 (CH2–OPiv), 64.8 (OCH2CH2O), 102.4 (CH(OCH2)2),
CDCl3): (Z)-2l: δ -5.3 (MeSi), -4.9 (MeSi), 18.0 (C-Si), 21.6 (CH3), 127.4 (CHPh), 128.3 (CHPh), 128.8 (CHPh), 138.7 (CPh), 165.4
25.6 (t-BuSi), 27.2 (2 × Me3C–C), 38.7 (Me3C), 38.8 (Me3C), 60.9 (C=N), 174.5 (C=O), 177.5 (C=O). HRMS (ESI): m/z calcd. for
(CH2–O), 64.8 (CH–O), 167.4 (C=N), 174.0 (C=O), 177.6 (C=O). [C23H33NO6+H+]: 420.2381, found: 420.2374. HPLC separation
(E)-2l (characteristic signals): δ 22.0 (CH3), 54.8 (CH2–O), 68.8 conditions: column: Chiralpak AD-3, 250 x 4.6 mm, temp.
(CH–O). HRMS (ESI): m/z calcd. for [C20H39NO5Si+Na+]: 25 °C, eluent: Hexane-i-PrOH, 90:10, 1 mL/min, detection at
424.2490, found: 424.2485.
5,5-Dimethoxy-3-phenyl-2-(pivaloyloxyimino)pentyl pivalate 2o
207 nm. tR = 4.9 min (Z-isomer, minor), 5.2 min (Z-isomer,
major), 6.3 min (E-isomer, major), 7.1 (E-isomer, minor).
3-Phenyl-2-(pivaloyloxyimino)pentane-1,5-diyl bis(2,2-
Oxime ester 2o was obtained from nitro compound syn-1o
(125 mg, 0.49 mmol) and pivaloyl chloride (0.13 mL, 0.13 g, 1.1
mmol) according to GP (r.t., 2 d). Column chromatography
(eluent: PE/EtOAc, 15:1, then 9:1) afforded 15 mg of nitroso
acetal 5, 71 mg of mixture 2o+5 (2o:5 = 6:1 (1H NMR)) and 71
mg of oxime ester 2o as colorless oils. Total yields: 2o: 64 %, 5:
12 %. Similar procedure for anti-1o (177 mg, 0.7 mmol) gave
182 mg (62%) of target oxime ester 2o. Oxime ester 2o: Rf =
dimethylpropanoate) 2r
Oxime ester 2r was obtained from nitro compound syn-1r (86
mg, 0.42 mmol) according to GP (r.t., 2 d) with the change:
increasing amounts of pivaloyl chloride (3.4 equiv., 0.18 mL,
0.17 g, 1.4 mmol) and NEt3 (3.8 equiv., 0.22 mL, 0.16 g, 1.6
mmol) were taken. Column chromatography (eluent:
PE/EtOAc, 10:1) afforded 156 mg (82 %) of target oxime ester
2r as colorless oil, that solidifies in a fridge. Rf = 0.44
(PE/EtOAc, 5:1, anisaldehyde). mp = 73-75 °C (PE/EtOAc, 10:1).
Similar procedure for anti-1r (94 mg, 0.45 mmol) gave 160 mg
(77 %) of target oxime ester 2r. Only (E)-2r. 1H NMR (300 MHz,
CDCl3): δ 1.16 (s, 18H, 2 × t-Bu), 1.27 (s, 9H, t-Bu), 2.37 (app q, J
= 7.0 Hz, CH2(4)), 4.00-4.18 (m, 2H, CH2(5)–OPiv), 4.55 (app t,
J= 7.8 Hz, CHPh), 4.62-4.72 (m, 2H, CH2(1)–OPiv), 7.23-7.33 (m,
5H, Ph). 13C NMR (75 MHz, DEPT, HSQC, CDCl3): δ 27.07
(Me3C), 27.12 (Me3C), 27.18 (Me3C), 29.8 (CH2(4)), 38.63
1
0.36 (PE/EtOAc, 5:1, anisaldehyde). Only (E)-2o. H NMR (300
MHz, COSY, CDCl3): δ 1.15 (s, 9H, t-Bu), 1.28 (s, 9H, t-Bu), 2.32
(dd, J = 7.9, 5.7 Hz, 1H, CH2), 3.30 (s, 3H, OMe), 3.31 (s, 3H,
OMe), 4.34 (t, J = 5.7 Hz, 1H, CH(OMe)2), 4.62 (t, J = 7.9 Hz, 1H,
CHPh), 4.68 (s, 2 H, CH2–O), 7.24-7.35 (m, 5H, Ph). 13C NMR (75
MHz, DEPT, HSQC, CDCl3): δ 27.0 (Me3C), 27.1 (Me3C), 33.9
(CH2), 38.6 (Me3C), 38.7 (Me3C), 40.3 (CHPh), 52.4 (OMe), 53.7
(OMe), 62.8 (CH2–O), 102.3 (CH(OMe)2), 127.5 (CHPh), 127.7
(CHPh), 128.9 (CHPh), 137.7 (CPh), 164.1 (C=N), 174.6 (C=O),
6 | J. Name., 2012, 00, 1-3
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins